Scarica l'app Stockscreener
21.90
4.63%
0.97
Ceribell Inc Borsa (CBLL) Ultime notizie
Ceribell stock price target reiterated at $30 by BTIG, citing growth - Investing.com Canada
BTIG Reiterates Buy Rating for CeriBell (CBLL) With Target Price of $30 | CBLL Stock News - GuruFocus
Ceribell extends leases for Sunnyvale offices through January 2028 By Investing.com - Investing.com Nigeria
Insider Selling: CeriBell (NASDAQ:CBLL) Director Sells 32,728 Shares of Stock - MarketBeat
FDA Clears Ceribell’s AI-Powered EEG as First Device for Continuous Delirium Monitoring - HIT Consultant
Ceribell, Inc. Extends Sunnyvale Office Leases - TipRanks
Ceribell extends leases for Sunnyvale offices through January 2028 - Investing.com
CBLL Gets FDA Consent for One-of-a-Kind Delirium Monitoring Solution - Your Wyoming Link
Josef Parvizi Sells 25,000 Shares of CeriBell (NASDAQ:CBLL) Stock - MarketBeat
Ceribell receives FDA 510K clearance for delirium screening, monitoring device - MSN
CeriBell (NASDAQ:CBLL) Shares Down 5.4% on Insider Selling - MarketBeat
Risk Analysis: Will CeriBell Inc stock split attract more investorsEarnings Miss & Verified Short-Term Trading Plans - moha.gov.vn
Insider Selling: CeriBell (NASDAQ:CBLL) Director Sells 5,000 Shares of Stock - MarketBeat
Ceribell director Robertson sells $100k in CBLL stock By Investing.com - Investing.com South Africa
Ceribell director Robertson sells $100k in CBLL stock - Investing.com
FDA OKs Ceribell’s Delirium Monitoring Solution - Medical Product Outsourcing
Buy Rating Affirmed for Ceribell, Inc. Due to Innovative Neonate Technology and FDA Clearance - TipRanks
Ceribell, Inc.’s Delirium Solution Gains Early FDA Clearance, Boosting Market Potential and Supporting Buy Rating - TipRanks
Ceribell, Inc. (CBLL) Gets a Buy from TD Cowen - The Globe and Mail
CeriBell Shares Rise 5.4% After FDA Clears First-of-Its-Kind Delirium EEG Tool - Nasdaq
There's Reason For Concern Over CeriBell, Inc.'s (NASDAQ:CBLL) Massive 69% Price Jump - 富途牛牛
CeriBell (NASDAQ:CBLL) Shares Gap UpTime to Buy? - MarketBeat
Ceribell stock price target raised to $29 from $20 at TD Cowen on FDA clearance - Investing.com
CeriBell Says FDA Clears Delirium Monitoring Solution; Shares Rise - marketscreener.com
Ceribell, Inc. Gains FDA Clearance for Delirium Device - TipRanks
Ceribell jumps on FDA clearance of brain monitoring device - TradingView — Track All Markets
Ceribell, Inc. Receives FDA Clearance for Delirium Monitoring Solution - TradingView — Track All Markets
Ceribell receives FDA 510k clearance for delirium screening, monitoring device - TipRanks
FDA clears Ceribell’s delirium monitoring system for ICU patients - Investing.com
FDA clears Ceribell’s delirium monitoring system for ICU patients By Investing.com - Investing.com India
Ceribell Receives FDA 510(k) Clearance for First-of-its-Kind Delirium Monitoring Solution - The Manila Times
Ceribell (Nasdaq: CBLL) gets FDA 510(k) clearance for first delirium monitoring device - Stock Titan
Ceribell CEO Chao Xingjuan sells $470k in CBLL stock By Investing.com - Investing.com Australia
CeriBell (NASDAQ:CBLL) CEO Sells $470,500.00 in Stock - MarketBeat
Ceribell CEO Chao Xingjuan sells $470k in CBLL stock - Investing.com
Ceribell Insider Sold Shares Worth $470,500, According to a Recent SEC Filing - marketscreener.com
David Foehr Sells 5,265 Shares of CeriBell (NASDAQ:CBLL) Stock - MarketBeat
Ceribell’s Foehr David sells $88k in Ceribell stock By Investing.com - Investing.com Australia
Ceribell’s Foehr David sells $88k in Ceribell stock - Investing.com India
Ceribell Senior VP David Foehr Sells 5,265 Shares - TradingView
VP Foehr Sells 5,265 ($88.6K) Of CeriBell Inc [CBLL] - TradingView
Insider Selling: CeriBell (NASDAQ:CBLL) Director Sells 827 Shares of Stock - MarketBeat
Geode Capital Management LLC Has $8.39 Million Stock Position in CeriBell, Inc. $CBLL - MarketBeat
CEO Chao Files To Sell 25,000 Of CeriBell Inc [CBLL] - TradingView
Robertson of Ceribell sells $13k in shares By Investing.com - Investing.com Nigeria
Insider Selling: CeriBell (NASDAQ:CBLL) CEO Sells 25,000 Shares of Stock - MarketBeat
CeriBell (NASDAQ:CBLL) CTO Sells $136,455.36 in Stock - MarketBeat
Robertson of Ceribell sells $13k in shares - Investing.com
Ceribell Director Rebecca B. Robertson Sells 827 Shares - TradingView
Chmn Robertson Sells 827 ($13.8K) Of CeriBell Inc [CBLL] - TradingView
1.42%
0.91%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):